MARKET

ACON

ACON

Aclarion Inc
NASDAQ
1.750
+0.090
+5.42%
After Hours: 1.720 -0.03 -1.71% 16:10 11/09 EST
OPEN
1.680
PREV CLOSE
1.660
HIGH
1.790
LOW
1.675
VOLUME
24.79K
TURNOVER
--
52 WEEK HIGH
9.36
52 WEEK LOW
1.544
MARKET CAP
5.04M
P/E (TTM)
-0.2208
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACON last week (1102-1106)?
Weekly Report · 11h ago
Weekly Report: what happened at ACON last week (1026-1030)?
Weekly Report · 11/02 09:52
HCA Healthcare (HCA) Q3 Earnings and Revenues Top Estimates
NASDAQ · 10/27 11:15
Weekly Report: what happened at ACON last week (1019-1023)?
Weekly Report · 10/26 09:52
Aclarion reports Nociscan validated by strong agreement with discography
TipRanks · 10/22 13:16
Aclarion reports 85% Q3 scan volume growth, $14.2M in cash
TipRanks · 10/20 13:10
Aclarion Publishes CEO Letter; Notes Q3 Scan Volumes Up 85% YoY And Up 117% YtD
Benzinga · 10/20 11:05
Weekly Report: what happened at ACON last week (1012-1016)?
Weekly Report · 10/19 09:52
More
About ACON
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.

Webull offers Aclarion Inc stock information, including NASDAQ: ACON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACON stock methods without spending real money on the virtual paper trading platform.